Filing Details

Accession Number:
0001062993-15-003576
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-25 17:02:52
Reporting Period:
2015-06-23
Filing Date:
2015-06-25
Accepted Time:
2015-06-25 17:02:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375378 Paul Gitman C/O Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook NY 11563
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2015-06-23 6,308 $13.60 58,133 No 4 M Direct
Common Stock, $0.001 Par Value Acquisiton 2015-06-23 15,000 $26.43 73,133 No 4 M Direct
Common Stock, $0.001 Par Value Acquisiton 2015-06-23 15,000 $20.00 88,133 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2015-06-23 6,308 $53.59 81,825 No 4 S Direct
Common Stock, $0.001 Par Value Disposition 2015-06-23 15,000 $51.84 66,825 No 4 S Direct
Common Stock, $0.001 Par Value Disposition 2015-06-23 15,000 $50.95 51,825 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.001 Par Value Stock Option (Right to Buy) Disposition 2015-06-23 6,308 $0.00 6,308 $13.60
Common Stock, $0.001 Par Value Stock Option (Right to Buy) Disposition 2015-06-23 15,000 $0.00 15,000 $26.43
Common Stock, $0.001 Par Value Stock Option (Right to Buy) Disposition 2015-06-23 15,000 $0.00 15,000 $20.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,692 2018-06-09 No 4 M Direct
0 2019-09-07 No 4 M Direct
0 2018-09-07 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
  2. The selling price of $53.5856 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $53.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The selling price of $51.8390 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The selling price of $50.9540 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
  6. The option was granted on September 8, 2009 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
  7. The option was granted on September 8, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.